IYH Among Health Care ETFs
End-of-day Nov 20, 2026 · 31 Health care ETFs by 3Y
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| Total return | −0.3% | −6.2% | −2.8% | +0.6% | +14.8% | +16.9% | +43.5% | +36.2% | +181.8% | +640.1% |
| Peer average | −1.3% | −6.4% | −4.5% | −5.9% | +13.4% | +17.5% | +58.2% | +19.5% | +146.1% | — |
| S&P 500 · VOO | −3.4% | −8.3% | −9.5% | −9.2% | +2.2% | +5.5% | +59.8% | +58.7% | +275.8% | — |
$164 of every $1,000 in IYH is Eli
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | LLYELI Lilly | Healthcare | 16.38% | $1,637.99 | 547K | $738.8M |
| 2 | JNJJohnson & Johnson | Healthcare | 9.77% | $977.46 | 1.7M | $440.9M |
| 3 | ABBVAbbvie | Healthcare | 7.62% | $762.30 | 1.2M | $343.8M |
| 4 | MRKMerck | Healthcare | 4.99% | $498.93 | 1.7M | $225.0M |
| 5 | UNHUnitedhealth Group | Healthcare | 4.53% | $453.15 | 618K | $204.4M |
| 6 | TMOThermo Fisher Scientific | Healthcare | 3.89% | $388.85 | 255K | $175.4M |
| 7 | AMGNAmgen | Healthcare | 3.60% | $359.66 | 370K | $162.2M |
| 8 | GILDGilead Sciences | Healthcare | 3.14% | $314.15 | 851K | $141.7M |
| 9 | ABTAbbott Laboratories | Healthcare | 2.73% | $273.32 | 1.2M | $123.3M |
| 10 | PFEPfizer | Healthcare | 2.38% | $238.12 | 3.9M | $107.4M |
| 11 | DHRDanaher | Healthcare | 2.18% | $218.36 | 433K | $98.5M |
| 12 | ISRGIntuitive Surgical | Healthcare | 2.18% | $218.00 | 241K | $98.3M |
| 13 | VRTXVertex Pharmaceuticals | Healthcare | 2.01% | $201.00 | 174K | $90.7M |
| 14 | MDTMedtronic | Healthcare | 1.88% | $187.56 | 841K | $84.6M |
| 15 | BMYBristol Myers Squibb | Healthcare | 1.81% | $180.91 | 1.4M | $81.6M |
of the $110B in 39 Health care ETFs
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | LLY | ELI Lilly | 16.38% |
| 2 | JNJ | Johnson & Johnson | 9.77% |
| 3 | ABBV | Abbvie | 7.62% |
| 4 | MRK | Merck & | 4.99% |
| 5 | UNH | Unitedhealth Group | 4.53% |
| 6 | TMO | Thermo Fisher Scientific | 3.89% |
| 7 | AMGN | Amgen | 3.60% |
| 8 | GILD | Gilead Sciences | 3.14% |
| 9 | ABT | Abbott Laboratories | 2.73% |
| 10 | PFE | Pfizer | 2.38% |
Estimated yearly cost excludes trading costs and assumes constant assets.
| Ex-date | Paid | Per share |
|---|---|---|
| Sep 15, 2026 | Sep 18, 2026 | $0.19 |
| Jun 15, 2026 | Jun 18, 2026 | $0.16 |
| Mar 17, 2026 | Mar 20, 2026 | $0.19 |
| Dec 16, 2025 | Dec 19, 2025 | $0.25 |
| Sep 16, 2025 | Sep 19, 2025 | $0.19 |
| Jun 16, 2025 | Jun 20, 2025 | $0.17 |
| Mar 18, 2025 | Mar 21, 2025 | $0.16 |
| Dec 17, 2024 | Dec 20, 2024 | $0.20 |
| Sep 25, 2024 | Sep 30, 2024 | $0.23 |
| Jun 11, 2024 | Jun 17, 2024 | $0.13 |
| Mar 21, 2024 | Mar 27, 2024 | $0.17 |
| Dec 20, 2023 | Dec 27, 2023 | $0.18 |